OpenLB
Open Library of Bioscience
Advanced Search
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia
Jun, 2021;34 (3): 185-192.

[Role of cefditoren in the treatment of community skin and soft tissue infections: revisiting the evidence].

M D Cabañero-Navalón, V García-Bustos, M Salavert Lletí
Author Information
  1. M Salavert Lletí: Miguel Salavert Lletí, Unidad de Enfermedades Infecciosas. Área Clínica Médica. Hospital Universitario y Politécnico La Fe, Valencia, Spain. Salavert_mig@gva.es.
PMID: 34027966 DOI: 10.37201/req/063.2021

Abstract

Cefditoren pivoxil is a third-generation oral cephalosporin with extended spectrum against Gram-negative, Gram-positive, and several anaerobic microorganisms, including those frequently implicated in skin and soft tissue infections (SSTI). Despite the fact that there are no approved breakpoint criteria for cefditoren susceptibility, many pharmacokinetic and pharmacodynamic studies reassert cefditoren as a good oral antibiotic for the treatment of SSTI. Regarding patients with SSTI, including those infections caused by Staphylococcus aureus y Streptococcus pyogenes, cefditoren showed high cure rates when compared to other oral cephalosporins.

Keywords

Cefditoren pivoxil cephalosporins skin and soft tissue infections

References

  1. Eur J Clin Microbiol Infect Dis. 2020 Dec;39(12):2387-2396 [PMID: 32700131]
  2. Enferm Infecc Microbiol Clin (Engl Ed). 2020 Aug - Sep;38(7):306-311 [PMID: 32085928]
  3. Rev Esp Quimioter. 2017 Dec;30(6):407-412 [PMID: 29199418]
  4. Clin Pract. 2021 Feb 01;11(1):65-74 [PMID: 33535501]
  5. Rev Esp Quimioter. 2009 Jun;22(2):57-61 [PMID: 19544097]
  6. Int J Antimicrob Agents. 2007 Feb;29(2):224-6 [PMID: 17175141]
  7. Rev Esp Quimioter. 2006 Sep;19(3):231-46 [PMID: 17099791]
  8. J Antimicrob Chemother. 2007 Aug;60(2):323-7 [PMID: 17562681]
  9. Antimicrob Agents Chemother. 2008 Mar;52(3):1184-6 [PMID: 18160517]
  10. Diagn Microbiol Infect Dis. 2008 Oct;62(2):210-5 [PMID: 18715733]
  11. Rev Esp Quimioter. 2009 Sep;22(3):144-50 [PMID: 19662548]
  12. World J Emerg Surg. 2018 Dec 14;13:58 [PMID: 30564282]
  13. Antimicrob Agents Chemother. 2007 Nov;51(11):3902-7 [PMID: 17724158]
  14. Taiwan J Obstet Gynecol. 2019 Nov;58(6):805-807 [PMID: 31759532]
  15. Clin Ther. 2002 Jul;24(7):1134-47 [PMID: 12182257]
  16. BMC Pediatr. 2017 Mar 14;17(1):73 [PMID: 28292283]
  17. J Antimicrob Chemother. 2002 Jan;49(1):31-40 [PMID: 11751764]
  18. Diagn Microbiol Infect Dis. 2000 Jun;37(2):143-6 [PMID: 10863109]
  19. J Chemother. 2008 Oct;20(5):561-9 [PMID: 19028617]
  20. Diagn Microbiol Infect Dis. 2010 Jul;67(3):251-60 [PMID: 20542206]
  21. J Antimicrob Chemother. 2002 Jul;50(1):33-41 [PMID: 12096004]
  22. Diagn Microbiol Infect Dis. 2009 Jun;64(2):202-12 [PMID: 19321284]
  23. Int J Antimicrob Agents. 2008 Apr;31(4):396-8 [PMID: 18178067]
  24. Diagn Microbiol Infect Dis. 2009 May;64(1):52-6 [PMID: 19232860]
  25. Multidiscip Respir Med. 2018 Nov 2;13:40 [PMID: 30410757]
  26. Clin Pharmacol Ther. 2003 Apr;73(4):338-47 [PMID: 12709724]
  27. J Antimicrob Chemother. 2002 Dec;50 Suppl S2:7-12 [PMID: 12556428]
  28. J Chemother. 2008 Apr;20(2):170-4 [PMID: 18467241]
  29. PLoS One. 2010 Aug 10;5(8):e12041 [PMID: 20706584]
  30. Neurol Sci. 2012 Dec;33(6):1393-6 [PMID: 22258360]
  31. J Antimicrob Chemother. 2007 Jul;60(1):156-8 [PMID: 17483149]
  32. Diagn Microbiol Infect Dis. 2001 Sep-Oct;41(1-2):1-14 [PMID: 11687308]
  33. Drugs. 2004;64(22):2597-618 [PMID: 15516158]
  34. Int J Antimicrob Agents. 2006 Jul;28(1):14-8 [PMID: 16777383]
  35. J Chemother. 2010 Jun;22(3):153-9 [PMID: 20566418]
  36. Drugs R D. 2012 Jun 1;12(2):65-70 [PMID: 22762844]
  37. Antimicrob Agents Chemother. 1988 Sep;32(9):1421-6 [PMID: 3264132]
  38. Antimicrob Agents Chemother. 2008 Jun;52(6):1945-51 [PMID: 17485507]
  39. BMC Infect Dis. 2012 Sep 25;12:228 [PMID: 23009290]
  40. Rev Esp Quimioter. 2007 Mar;20(1):51-60 [PMID: 17530036]
  41. J Chemother. 2010 Nov;22 Suppl 1:3-4 [PMID: 21097386]
  42. Int J Infect Dis. 2012 Dec;16(12):e843-9 [PMID: 22951426]
  43. Eur Rev Med Pharmacol Sci. 2014;18(3):321-32 [PMID: 24563430]

MeSH Term

Anti-Bacterial Agents
Cephalosporins
Humans
Soft Tissue Infections

Chemicals

Anti-Bacterial Agents
Cephalosporins
cefditoren
Journal Article Review

Word Cloud

Created with Highcharts 10.0.0cefditorenoralskinsofttissueinfectionsSSTICefditorenpivoxilincludingtreatmentcephalosporinsthird-generationcephalosporinextendedspectrumGram-negativeGram-positiveseveralanaerobicmicroorganismsfrequentlyimplicatedDespitefactapprovedbreakpointcriteriasusceptibilitymanypharmacokineticpharmacodynamicstudiesreassertgoodantibioticRegardingpatientscausedStaphylococcusaureusyStreptococcuspyogenesshowedhighcureratescompared[Rolecommunityinfections:revisitingevidence]

Similar Articles

Cited By